HEADER HYDROLASE/VIRAL PROTEIN 28-DEC-23 8XN2 TITLE SARS-COV-2 OMICRON EG.5.1 RBD IN COMPLEX WITH HUMAN ACE2 (LOCAL TITLE 2 REFINED FROM THE SPIKE PROTEIN) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACE-RELATED CARBOXYPEPTIDASE,ANGIOTENSIN-CONVERTING ENZYME COMPND 5 HOMOLOG,ACEH,METALLOPROTEASE MPROT15; COMPND 6 EC: 3.4.17.23,3.4.17.-; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: SPIKE PROTEIN S1; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RBD; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: OMICRON EG.5.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACE2, UNQ868/PRO1885; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_TAXID: 2697049; SOURCE 12 GENE: S, 2; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS SARS-COV-2, OMICRON, EG.5.1, SPIKE PROTEIN, HUMAN ACE2, RBD, VIRAL KEYWDS 2 PROTEIN, HYDROLASE-VIRAL PROTEIN COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR L.J.LI,Y.H.GU,K.Y.SHI,J.X.QI,G.F.GAO REVDAT 1 03-JUL-24 8XN2 0 JRNL AUTH L.J.LI,Z.P.XU,K.F.LIU,G.F.GAO JRNL TITL STRUCTURAL BASIS OF RECEPTOR BINDING AND IMMUNE ESCAPE FOR JRNL TITL 2 SARS-COV-2 OMICRON BA.2.86, EG.5, EG.5.1 AND HV.1 JRNL TITL 3 SUB-VARIANTS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.790 REMARK 3 NUMBER OF PARTICLES : 403003 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8XN2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-JAN-24. REMARK 100 THE DEPOSITION ID IS D_1300043836. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 OMICRON EG.5.1 RBD REMARK 245 (RECEPTOR BINDING DOMAIN) IN REMARK 245 COMPLEX WITH HUMAN ACE2 REMARK 245 (ANGIOTENSIN CONVERTING ENZYME REMARK 245 2) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 615 REMARK 465 HIS A 616 REMARK 465 HIS A 617 REMARK 465 HIS A 618 REMARK 465 HIS A 619 REMARK 465 HIS A 620 REMARK 465 HIS A 621 REMARK 465 ARG B 319 REMARK 465 VAL B 320 REMARK 465 GLN B 321 REMARK 465 PRO B 322 REMARK 465 THR B 323 REMARK 465 GLU B 324 REMARK 465 SER B 325 REMARK 465 ILE B 326 REMARK 465 VAL B 327 REMARK 465 ARG B 328 REMARK 465 PHE B 329 REMARK 465 PRO B 330 REMARK 465 ASN B 331 REMARK 465 PRO B 527 REMARK 465 LYS B 528 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 THR B 531 REMARK 465 ASN B 532 REMARK 465 LEU B 533 REMARK 465 VAL B 534 REMARK 465 LYS B 535 REMARK 465 ASN B 536 REMARK 465 LYS B 537 REMARK 465 CYS B 538 REMARK 465 VAL B 539 REMARK 465 ASN B 540 REMARK 465 PHE B 541 REMARK 465 HIS B 542 REMARK 465 HIS B 543 REMARK 465 HIS B 544 REMARK 465 HIS B 545 REMARK 465 HIS B 546 REMARK 465 HIS B 547 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 91 27.19 -72.56 REMARK 500 THR A 92 -48.43 -135.57 REMARK 500 ALA A 301 62.93 61.23 REMARK 500 ASN A 338 -121.34 53.05 REMARK 500 ILE A 484 -63.49 -95.85 REMARK 500 LYS A 541 56.77 -95.37 REMARK 500 THR B 345 -3.45 66.56 REMARK 500 THR B 346 115.55 -162.15 REMARK 500 ALA B 348 -144.96 57.82 REMARK 500 THR B 523 7.20 59.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 706 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 94.2 REMARK 620 3 GLU A 402 OE1 61.1 115.5 REMARK 620 4 GLU A 402 OE2 105.8 81.6 55.8 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-38495 RELATED DB: EMDB REMARK 900 SARS-COV-2 OMICRON EG.5.1 RBD IN COMPLEX WITH HUMAN ACE2 (LOCAL REMARK 900 REFINED FROM THE SPIKE PROTEIN) DBREF 8XN2 A 19 615 UNP Q9BYF1 ACE2_HUMAN 19 615 DBREF 8XN2 B 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 SEQADV 8XN2 HIS A 616 UNP Q9BYF1 EXPRESSION TAG SEQADV 8XN2 HIS A 617 UNP Q9BYF1 EXPRESSION TAG SEQADV 8XN2 HIS A 618 UNP Q9BYF1 EXPRESSION TAG SEQADV 8XN2 HIS A 619 UNP Q9BYF1 EXPRESSION TAG SEQADV 8XN2 HIS A 620 UNP Q9BYF1 EXPRESSION TAG SEQADV 8XN2 HIS A 621 UNP Q9BYF1 EXPRESSION TAG SEQADV 8XN2 HIS B 339 UNP P0DTC2 GLY 339 VARIANT SEQADV 8XN2 THR B 346 UNP P0DTC2 ARG 346 VARIANT SEQADV 8XN2 ILE B 368 UNP P0DTC2 LEU 368 VARIANT SEQADV 8XN2 PHE B 371 UNP P0DTC2 SER 371 VARIANT SEQADV 8XN2 PRO B 373 UNP P0DTC2 SER 373 VARIANT SEQADV 8XN2 PHE B 375 UNP P0DTC2 SER 375 VARIANT SEQADV 8XN2 ALA B 376 UNP P0DTC2 THR 376 VARIANT SEQADV 8XN2 ASN B 405 UNP P0DTC2 ASP 405 VARIANT SEQADV 8XN2 SER B 408 UNP P0DTC2 ARG 408 VARIANT SEQADV 8XN2 ASN B 417 UNP P0DTC2 LYS 417 VARIANT SEQADV 8XN2 LYS B 440 UNP P0DTC2 ASN 440 VARIANT SEQADV 8XN2 PRO B 445 UNP P0DTC2 VAL 445 VARIANT SEQADV 8XN2 SER B 446 UNP P0DTC2 GLY 446 VARIANT SEQADV 8XN2 LEU B 456 UNP P0DTC2 PHE 456 VARIANT SEQADV 8XN2 LYS B 460 UNP P0DTC2 ASN 460 VARIANT SEQADV 8XN2 ASN B 477 UNP P0DTC2 SER 477 VARIANT SEQADV 8XN2 LYS B 478 UNP P0DTC2 THR 478 VARIANT SEQADV 8XN2 ALA B 484 UNP P0DTC2 GLU 484 VARIANT SEQADV 8XN2 PRO B 486 UNP P0DTC2 PHE 486 VARIANT SEQADV 8XN2 SER B 490 UNP P0DTC2 PHE 490 VARIANT SEQADV 8XN2 ARG B 498 UNP P0DTC2 GLN 498 VARIANT SEQADV 8XN2 TYR B 501 UNP P0DTC2 ASN 501 VARIANT SEQADV 8XN2 HIS B 505 UNP P0DTC2 TYR 505 VARIANT SEQADV 8XN2 HIS B 542 UNP P0DTC2 EXPRESSION TAG SEQADV 8XN2 HIS B 543 UNP P0DTC2 EXPRESSION TAG SEQADV 8XN2 HIS B 544 UNP P0DTC2 EXPRESSION TAG SEQADV 8XN2 HIS B 545 UNP P0DTC2 EXPRESSION TAG SEQADV 8XN2 HIS B 546 UNP P0DTC2 EXPRESSION TAG SEQADV 8XN2 HIS B 547 UNP P0DTC2 EXPRESSION TAG SEQRES 1 A 603 SER THR ILE GLU GLU GLN ALA LYS THR PHE LEU ASP LYS SEQRES 2 A 603 PHE ASN HIS GLU ALA GLU ASP LEU PHE TYR GLN SER SER SEQRES 3 A 603 LEU ALA SER TRP ASN TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 603 ASN VAL GLN ASN MET ASN ASN ALA GLY ASP LYS TRP SER SEQRES 5 A 603 ALA PHE LEU LYS GLU GLN SER THR LEU ALA GLN MET TYR SEQRES 6 A 603 PRO LEU GLN GLU ILE GLN ASN LEU THR VAL LYS LEU GLN SEQRES 7 A 603 LEU GLN ALA LEU GLN GLN ASN GLY SER SER VAL LEU SER SEQRES 8 A 603 GLU ASP LYS SER LYS ARG LEU ASN THR ILE LEU ASN THR SEQRES 9 A 603 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN PRO SEQRES 10 A 603 ASP ASN PRO GLN GLU CYS LEU LEU LEU GLU PRO GLY LEU SEQRES 11 A 603 ASN GLU ILE MET ALA ASN SER LEU ASP TYR ASN GLU ARG SEQRES 12 A 603 LEU TRP ALA TRP GLU SER TRP ARG SER GLU VAL GLY LYS SEQRES 13 A 603 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 603 ASN GLU MET ALA ARG ALA ASN HIS TYR GLU ASP TYR GLY SEQRES 15 A 603 ASP TYR TRP ARG GLY ASP TYR GLU VAL ASN GLY VAL ASP SEQRES 16 A 603 GLY TYR ASP TYR SER ARG GLY GLN LEU ILE GLU ASP VAL SEQRES 17 A 603 GLU HIS THR PHE GLU GLU ILE LYS PRO LEU TYR GLU HIS SEQRES 18 A 603 LEU HIS ALA TYR VAL ARG ALA LYS LEU MET ASN ALA TYR SEQRES 19 A 603 PRO SER TYR ILE SER PRO ILE GLY CYS LEU PRO ALA HIS SEQRES 20 A 603 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 603 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 603 ASP VAL THR ASP ALA MET VAL ASP GLN ALA TRP ASP ALA SEQRES 23 A 603 GLN ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 603 VAL GLY LEU PRO ASN MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 603 SER MET LEU THR ASP PRO GLY ASN VAL GLN LYS ALA VAL SEQRES 26 A 603 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 603 ARG ILE LEU MET CYS THR LYS VAL THR MET ASP ASP PHE SEQRES 28 A 603 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 603 MET ALA TYR ALA ALA GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 603 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 603 SER LEU SER ALA ALA THR PRO LYS HIS LEU LYS SER ILE SEQRES 32 A 603 GLY LEU LEU SER PRO ASP PHE GLN GLU ASP ASN GLU THR SEQRES 33 A 603 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 603 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 603 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS ASP GLN TRP SEQRES 36 A 603 MET LYS LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 603 VAL VAL GLU PRO VAL PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 603 PRO ALA SER LEU PHE HIS VAL SER ASN ASP TYR SER PHE SEQRES 39 A 603 ILE ARG TYR TYR THR ARG THR LEU TYR GLN PHE GLN PHE SEQRES 40 A 603 GLN GLU ALA LEU CYS GLN ALA ALA LYS HIS GLU GLY PRO SEQRES 41 A 603 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 603 GLN LYS LEU PHE ASN MET LEU ARG LEU GLY LYS SER GLU SEQRES 43 A 603 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 603 ASN MET ASN VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 603 LEU PHE THR TRP LEU LYS ASP GLN ASN LYS ASN SER PHE SEQRES 46 A 603 VAL GLY TRP SER THR ASP TRP SER PRO TYR ALA ASP HIS SEQRES 47 A 603 HIS HIS HIS HIS HIS SEQRES 1 B 229 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 B 229 ILE THR ASN LEU CYS PRO PHE HIS GLU VAL PHE ASN ALA SEQRES 3 B 229 THR THR PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 B 229 ILE SER ASN CYS VAL ALA ASP TYR SER VAL ILE TYR ASN SEQRES 5 B 229 PHE ALA PRO PHE PHE ALA PHE LYS CYS TYR GLY VAL SER SEQRES 6 B 229 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 B 229 ALA ASP SER PHE VAL ILE ARG GLY ASN GLU VAL SER GLN SEQRES 8 B 229 ILE ALA PRO GLY GLN THR GLY ASN ILE ALA ASP TYR ASN SEQRES 9 B 229 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 B 229 TRP ASN SER ASN LYS LEU ASP SER LYS PRO SER GLY ASN SEQRES 11 B 229 TYR ASN TYR LEU TYR ARG LEU LEU ARG LYS SER LYS LEU SEQRES 12 B 229 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 B 229 ALA GLY ASN LYS PRO CYS ASN GLY VAL ALA GLY PRO ASN SEQRES 14 B 229 CYS TYR SER PRO LEU GLN SER TYR GLY PHE ARG PRO THR SEQRES 15 B 229 TYR GLY VAL GLY HIS GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 B 229 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 B 229 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 B 229 ASN PHE HIS HIS HIS HIS HIS HIS HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG A 701 14 HET NAG A 702 14 HET NAG A 703 14 HET NAG A 704 14 HET NAG A 705 14 HET ZN A 706 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 7(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 9 ZN ZN 2+ HELIX 1 AA1 THR A 20 ASN A 53 1 34 HELIX 2 AA2 THR A 55 GLN A 81 1 27 HELIX 3 AA3 MET A 82 TYR A 83 5 2 HELIX 4 AA4 PRO A 84 ILE A 88 5 5 HELIX 5 AA5 THR A 92 GLN A 101 1 10 HELIX 6 AA6 SER A 109 GLY A 130 1 22 HELIX 7 AA7 GLY A 147 SER A 155 1 9 HELIX 8 AA8 ASP A 157 ASN A 194 1 38 HELIX 9 AA9 ASP A 198 GLY A 205 1 8 HELIX 10 AB1 ASP A 206 GLU A 208 5 3 HELIX 11 AB2 GLY A 220 TYR A 252 1 33 HELIX 12 AB3 TRP A 275 TYR A 279 5 5 HELIX 13 AB4 VAL A 293 GLN A 300 1 8 HELIX 14 AB5 ASP A 303 VAL A 318 1 16 HELIX 15 AB6 THR A 324 SER A 331 1 8 HELIX 16 AB7 THR A 365 TYR A 385 1 21 HELIX 17 AB8 ALA A 386 GLN A 388 5 3 HELIX 18 AB9 GLY A 399 ALA A 413 1 15 HELIX 19 AC1 THR A 414 GLY A 422 1 9 HELIX 20 AC2 ASP A 431 VAL A 447 1 17 HELIX 21 AC3 GLY A 448 GLY A 466 1 19 HELIX 22 AC4 PRO A 469 ASP A 471 5 3 HELIX 23 AC5 GLN A 472 ILE A 484 1 13 HELIX 24 AC6 CYS A 498 SER A 502 5 5 HELIX 25 AC7 LEU A 503 ASN A 508 1 6 HELIX 26 AC8 PHE A 512 ALA A 533 1 22 HELIX 27 AC9 PRO A 538 CYS A 542 5 5 HELIX 28 AD1 SER A 547 GLY A 561 1 15 HELIX 29 AD2 PRO A 565 GLY A 575 1 11 HELIX 30 AD3 VAL A 581 PHE A 588 1 8 HELIX 31 AD4 PHE A 588 ASN A 599 1 12 HELIX 32 AD5 PRO B 337 PHE B 342 1 6 HELIX 33 AD6 TYR B 365 PHE B 371 1 7 HELIX 34 AD7 PRO B 384 ASN B 388 5 5 HELIX 35 AD8 GLY B 404 SER B 408 5 5 HELIX 36 AD9 GLY B 416 ASN B 422 1 7 HELIX 37 AE1 SER B 438 SER B 443 1 6 SHEET 1 AA1 2 LYS A 131 ASN A 134 0 SHEET 2 AA1 2 ASN A 137 LEU A 143 -1 O LEU A 142 N VAL A 132 SHEET 1 AA2 2 LEU A 262 PRO A 263 0 SHEET 2 AA2 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA3 2 THR A 347 GLY A 352 0 SHEET 2 AA3 2 ASP A 355 LEU A 359 -1 O ARG A 357 N TRP A 349 SHEET 1 AA4 5 ASN B 354 ILE B 358 0 SHEET 2 AA4 5 ASN B 394 ILE B 402 -1 O VAL B 395 N ILE B 358 SHEET 3 AA4 5 TYR B 508 GLU B 516 -1 O SER B 514 N TYR B 396 SHEET 4 AA4 5 GLY B 431 ASN B 437 -1 N TRP B 436 O ARG B 509 SHEET 5 AA4 5 ALA B 376 CYS B 379 -1 N LYS B 378 O VAL B 433 SHEET 1 AA5 2 LEU B 452 ARG B 454 0 SHEET 2 AA5 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA6 2 TYR B 473 GLN B 474 0 SHEET 2 AA6 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SSBOND 1 CYS A 133 CYS A 141 1555 1555 2.03 SSBOND 2 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 3 CYS A 530 CYS A 542 1555 1555 2.03 SSBOND 4 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 5 CYS B 379 CYS B 432 1555 1555 2.03 SSBOND 6 CYS B 391 CYS B 525 1555 1555 2.03 SSBOND 7 CYS B 480 CYS B 488 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 701 1555 1555 1.44 LINK ND2 ASN A 90 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 103 C1 NAG A 702 1555 1555 1.46 LINK ND2 ASN A 322 C1 NAG A 705 1555 1555 1.46 LINK ND2 ASN A 432 C1 NAG A 703 1555 1555 1.45 LINK ND2 ASN A 546 C1 NAG A 704 1555 1555 1.46 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.40 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.40 LINK NE2 HIS A 374 ZN ZN A 706 1555 1555 2.15 LINK NE2 HIS A 378 ZN ZN A 706 1555 1555 2.16 LINK OE1 GLU A 402 ZN ZN A 706 1555 1555 2.37 LINK OE2 GLU A 402 ZN ZN A 706 1555 1555 2.28 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000